tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CYBN Stock Latest News

Cybin Secures $175 Million in Direct Offering to Advance Clinical Programs
Company AnnouncementsCybin Secures $175 Million in Direct Offering to Advance Clinical Programs
2d ago
6K
CYBN
Psychedelic: Clearmind reports results from first cohort in AUD trial
PremiumThe Fly
Psychedelic: Clearmind reports results from first cohort in AUD trial
8d ago
PBM
CMND
Cybin price target lowered to $45 from $70 at Canaccord
PremiumThe Fly
Cybin price target lowered to $45 from $70 at Canaccord
8d ago
CYBN
Cybin Inc.: Strategic Positioning and Financial Strength Bolster Buy Rating
PremiumRatings
Cybin Inc.: Strategic Positioning and Financial Strength Bolster Buy Rating
9d ago
CYBN
Cybin price target lowered to $55 from $150 at H.C. Wainwright
PremiumThe Fly
Cybin price target lowered to $55 from $150 at H.C. Wainwright
14d ago
CYBN
Cybin, Inc. Reports Q2 2026 Financial Results
PremiumCompany AnnouncementsCybin, Inc. Reports Q2 2026 Financial Results
14d ago
CYBN
Cybin, Inc. Navigates Progress and Challenges in Earnings Call
Premium
Company Announcements
Cybin, Inc. Navigates Progress and Challenges in Earnings Call
14d ago
CYBN
Psychedelic: Atai Beckley, Cybin report quarterly earnings
Premium
The Fly
Psychedelic: Atai Beckley, Cybin report quarterly earnings
15d ago
PBM
ABBV
Cybin reports Q2 EPS ($1.39), consensus ($1.33)
PremiumThe Fly
Cybin reports Q2 EPS ($1.39), consensus ($1.33)
15d ago
CYBN
Cybin Inc. Advances Clinical Trials with Strong Financial Backing
PremiumCompany Announcements
Cybin Inc. Advances Clinical Trials with Strong Financial Backing
15d ago
CYBN
Cybin to Present at Jefferies Global Healthcare Conference
PremiumCompany Announcements
Cybin to Present at Jefferies Global Healthcare Conference
16d ago
CYBN
Cybin to Release Q2 Financial Results and Business Update
PremiumCompany Announcements
Cybin to Release Q2 Financial Results and Business Update
22d ago
CYBN
Cybin to Engage in Healthcare Innovation Conference
PremiumCompany AnnouncementsCybin to Engage in Healthcare Innovation Conference
23d ago
CYBN
Cybin’s CMO to Join Panel at 2025 Milken Institute Health Summit
Premium
Company Announcements
Cybin’s CMO to Join Panel at 2025 Milken Institute Health Summit
25d ago
CYBN
Cybin Secures $175 Million in Direct Offering to Boost Mental Health Initiatives
Premium
Company Announcements
Cybin Secures $175 Million in Direct Offering to Boost Mental Health Initiatives
28d ago
CYBN
Cybin Inc. Secures $175 Million in Direct Offering to Fund Clinical Programs
PremiumCompany Announcements
Cybin Inc. Secures $175 Million in Direct Offering to Fund Clinical Programs
1M ago
CYBN
Cybin Advances Clinical Programs in Psychedelic Therapeutics
PremiumCompany Announcements
Cybin Advances Clinical Programs in Psychedelic Therapeutics
2M ago
CYBN
Cybin Inc. Strengthens U.S. Market Position with New SEC Filing
PremiumCompany Announcements
Cybin Inc. Strengthens U.S. Market Position with New SEC Filing
2M ago
6K
CYBN
Cybin Inc. Announces CEO Transition as of September 2, 2025
PremiumCompany Announcements
Cybin Inc. Announces CEO Transition as of September 2, 2025
2M ago
6K
CYBN
Cybin’s Promising Clinical Advancements and Strategic Positioning Justify Buy Rating
PremiumRatingsCybin’s Promising Clinical Advancements and Strategic Positioning Justify Buy Rating
3M ago
CYBN
Psychedelic: Cybin completes enrollment in CYB004 Phase 2 study
Premium
The Fly
Psychedelic: Cybin completes enrollment in CYB004 Phase 2 study
3M ago
CYBN
DRUG
Cybin to Engage in TD Cowen’s Neuropsychiatry Summit
Premium
Company Announcements
Cybin to Engage in TD Cowen’s Neuropsychiatry Summit
3M ago
CYBN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >